Skip to main content

Table 4 Differences between groups A and B at stage 1 at T0-T8 and T9-T14

From: Long-term treatment with low-dose medicine in chronic childhood eczema: a double-blind two-stage randomized control trial

Variable Group A T0-T8 Group B T0-T8 Difference between B-A groups P value Group A
T9-T14 FU
Group B
T9-T14 FU
Difference between B-A groups p value
% decrease of the SCORAD index 41.5 53.8 12.3 0.014 19.9 21.9 2.0 0.77
Conventional therapy (months/person) 30 16 −14 0.074 30 9 −21 0.077
% of patients treated with steroidsa 32.1 23.1 −9.0 0.073 17.9 15.3 −2.6 0.15
% of patients treated with antihistaminesa 35.7 19.2 −16.5 0.003 32.1 11.5 −20.6 0.028
  1. aWe considered treated with steroids or antihistamines subjects that took at least one medication during the study. (FU: follow-up)